WHAT'S TRENDING

5 most popular innovation stories in Houston this week

From Houston's fastest-growing companies and three female innovators to know to coronavirus tracking tool and COVID-19 resources for startups, here's what you're reading this week. Pexels

Editor's note: The Houston innovation ecosystem is joining together — virtually — to provide health and resources to those affected by coronavirus — from fashion entrepreneurs designing face masks to 3D printers making personal protective equipment. Both non-COVID-19 news, like Houston's fastest-growing companies and three female innovators to know, and virus-related articles, like a coronavirus tracking tool and resources for startups, trended this week.

3 female Houston innovators to know this week

This week's innovators to know are Allie Danziger, Sylvia Kampshoff, and Brittany Barreto. Courtesy photos

This one's for the ladies. InnovationMap's weekly roundup of innovators to know features three female founders — one is offering her advice on crisis communications, one is innovating the at-home workout, and one is planning on making Houston a city for femtech. Continue reading.

Houston startups turn to digital pitches during coronavirus shutdown

Three Houston-based startups logged on to pitch digitally this week since SXSW was canceled. Getty Images

When SXSW canceled a couple weeks ago, event organizers were sent into a frantic scramble of how to salvage some aspect of their plans while also balancing lost deposits, canceled travel, and so much more.

Three pitch events associated with SXSW and featuring Houston startups went on in a digital capacity, and the social distancing has only just began. Michele Price who leads Startup Grind Houston says the Google-backed organization with locations everywhere is aware of the need for digital networking options. Continue reading.

Houston startup creates COVID-19 tracking tool

A Houston startup has created a web tool for tracking the coronavirus. Pexels

AHouston tech startup has created a web application to give the residents of Harris County all the local information on COVID-19 in the palm of their hand.

Predictive Solutions uses a map tool to indicate the county's nearby testing locations as well as cases that have been self reported in the area through the tool. While not trying to be comprehensive, the website is trying to track trends with the disease. Continue reading.

These are the 5 fastest-growing companies in Houston, according to a recent report

Inc. magazine has identified the fastest-growing companies in Houston. Nick Bee/Pexels

Bellaire-based startup Instafuel is pumping up its revenue in a big way.

Among the 250 fastest-growing companies in Texas identified by Inc. magazine, Instafuel tops the group of businesses based in the Houston metro area and ranks fifth statewide. Houston-based companies make up 68 of the state's fast-growing companies — eight Houston companies make up the top 25 list. Continue reading.

4 resources for Houston startups and small businesses during COVID-19 shutdown

Small businesses and startups are likely to hurt — and hurt bad — from COVID-19's affect on the economy. Here are some resources to get support. Photo by Hero Images

It's a trying time for the world, and Houston small businesses and startups have been put in a difficult spot. From having to work remotely or being forced to close or scale back operations due to mandates from the government, entrepreneurs are having to figure out their new normals.

However, organizations have leapt at the chance to help their fellow Houstonians, and a number of resources have appeared to provide aid to startups, from advice and resources to grants. Continue reading.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted